<DOC>
	<DOCNO>NCT00451984</DOCNO>
	<brief_summary>The response vaccination hepatitis reduce patient HIV infection . The hypothesis study adjuvant interleukin-2 administer subcutaneously time vaccination improve response rate .</brief_summary>
	<brief_title>Hepatitis Vaccination HIV Infection : Role Adjuvant Interleukin-2</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Interleukin-2</mesh_term>
	<criteria>Adults stable antiretroviral therapy negative hepatitis A B Prior hepatitis A B</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>interleukin-2</keyword>
	<keyword>vaccination</keyword>
	<keyword>treatment experience</keyword>
</DOC>